Financhill
Back

BMO MSCI ACWI Paris Aligned Clmt Eq ETF Vs. NovoCure Industry Stock Comparison

Buy
55

ZGRN.TO
BMO MSCI ACWI Paris Aligned Clmt Eq ETF

Last Price:
41.10
Seasonality Move:
5.38%
Buy
75

NVCR
NovoCure

Last Price:
33.40
Seasonality Move:
-5.24%
Buy
55
BMO MSCI ACWI Paris Aligned Clmt Eq ETF (ZGRN.TO) is a Buy

Is BMO MSCI ACWI Paris Aligned Clmt Eq ETF a Buy, Sell or Hold?

  • The current BMO MSCI ACWI Paris Aligned Clmt Eq ETF [ZGRN.TO] share price is $41.10. The Score for ZGRN.TO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • ZGRN.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $33.41. The Score for NVCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ZGRN.TO Stock Price Chart

What is BMO MSCI ACWI Paris Aligned Clmt Eq ETF's stock price today?

  • The BMO MSCI ACWI Paris Aligned Clmt Eq ETF share price today is $41.10
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZGRN.TO is experiencing slight buying pressure.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $33.41
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

ZGRN.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.52 Buy
Relative Strength Index (14 RSI): 76.13 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.5 - 40.82) Buy
Bollinger Bands (100): (36.7 - 39.74) Buy

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.78 Buy
Relative Strength Index (14 RSI): 75.34 Buy
Chaikin Money Flow: 1118573 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.36 - 28.56) Buy
Bollinger Bands (100): (14.7 - 22.78) Buy

ZGRN.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.98 Buy
20-day SMA: 40.27 Buy
50-day SMA: 39.47 Buy
200-day SMA: 36.8 Buy
8-day EMA: 40.95 Buy
20-day EMA: 40.44 Buy
50-day EMA: 39.57 Buy
200-day EMA: 36.9 Buy

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.6 Buy
20-day SMA: 23.68 Buy
50-day SMA: 19.33 Buy
200-day SMA: 17.9 Buy
8-day EMA: 29.53 Buy
20-day EMA: 25.45 Buy
50-day EMA: 21.38 Buy
200-day EMA: 19.88 Buy

BMO MSCI ACWI Paris Aligned Clmt Eq ETF Earnings Growth & ZGRN.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.

BMO MSCI ACWI Paris Aligned Clmt Eq ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):